New Approach Methodologies for the Toxicity Assessment of Nanomaterials

A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".

Deadline for manuscript submissions: 30 November 2024 | Viewed by 3901

Special Issue Editors


E-Mail Website
Guest Editor
Polaris Research Centre, Department of Earth and Environmental Sciences, University of Milano-Bicocca, Piazza della Scienza, 1, 20126 Milan, Italy
Interests: nano-toxicology; in vitro advanced models; inhalation toxicology; safe and sustainable by design nanomaterial; airborne ultrafine particles

E-Mail Website
Guest Editor
The Climate and Environmental Research Institute (NILU), Oslo, Norway
Interests: nanosafety; particles inhalation; inhalation toxicology; in vitro toxicology

Special Issue Information

Dear Colleagues,

Despite the increasing amount of data available about the toxicity of nanomaterials (NMs), there is still a need to understand the hazards they cause to humans and the environment, especially in relation to real-world exposure scenarios. The definition of standardized approaches to test the toxicity of NMs is another identified need, especially in the view of the next generation risk assessment (NGRA) and the safe and sustainable by design (SSbD) framework. In this context, new approach methodologies (NAMs) represent a powerful and promising tool to reduce animal testing and facilitate the risk assessment of the large number of existing nanoforms.

The aim of this Special Issue is to encourage scientists to publish their theoretical and experimental research on the toxicity assessment of NMs using NAMs as an alternative to mammalian in vivo models. The specific topics covered may include the following:

  • New approach methodologies (NAMs), including in silico, in chemico, and in vitro models for the human and environmental risk assessment of nanoparticles;
  • The role of nanoparticles (including environmental ultrafine particles, engineered NMs, and bio-based and advanced NMs) in biological process including cytotoxicity, oxidative stress, inflammation, and genotoxicity;
  • The impacts and adverse effects of nanoparticles on lung in vitro models, and other target organs, including innovative 3D in vitro models and in silico approaches;
  • The toxicity/safety of NMs and nano-enabled functional products (antibacterial, antiviral, and bio-nanomaterials) by using cell culture models, advanced complex in vitro models, and non-mammalian model organisms.

Original research papers should fulfill the quality criteria for human toxicity and ecotoxicological studies that need to be included in risk assessment, respecting the minimum requirements for the characterization and data reporting of NMs (e.g., as indicated by the GUIDEnano approach).

With this collection, we aim at supporting the progress of the knowledge within the field of nanotoxicology and the efforts towards the harmonization and standardization of NAMs applied to the toxicity assessment of NMs. 

Dr. Rossella Bengalli
Dr. Eleonora Longhin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanoparticles
  • nanomaterials
  • in vitro toxicity
  • new approach methodologies (NAMs)
  • in vitro models
  • alternative to in vivo models
  • adverse outcome pathways
  • in silico models
  • safe and sustainable by design

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

18 pages, 3863 KiB  
Article
Toward Standardization of a Lung New Approach Model for Toxicity Testing of Nanomaterials
by Elisabeth Elje, Laura M. A. Camassa, Sergey Shaposhnikov, Kristine Haugen Anmarkrud, Øivind Skare, Asbjørn M. Nilsen, Shan Zienolddiny-Narui and Elise Rundén-Pran
Nanomaterials 2024, 14(23), 1888; https://doi.org/10.3390/nano14231888 - 24 Nov 2024
Viewed by 278
Abstract
This study represents an attempt toward the standardization of pulmonary NAMs and the development of a novel approach for toxicity testing of nanomaterials. Laboratory comparisons are challenging yet essential for identifying existing limitations and proposing potential solutions. Lung cells cultivated and exposed at [...] Read more.
This study represents an attempt toward the standardization of pulmonary NAMs and the development of a novel approach for toxicity testing of nanomaterials. Laboratory comparisons are challenging yet essential for identifying existing limitations and proposing potential solutions. Lung cells cultivated and exposed at the air-liquid interface (ALI) more accurately represent the physiology of human lungs and pulmonary exposure scenarios than submerged cell and exposure models. A triculture cell model system was used, consisting of human A549 lung epithelial cells and differentiated THP-1 macrophages on the apical side, with EA.hy926 endothelial cells on the basolateral side. The cells were exposed to silver nanoparticles NM-300K for 24 h. The model used here showed to be applicable for assessing the hazards of nanomaterials and chemicals, albeit with some limitations. Cellular viability was measured using the alamarBlue assay, DNA damage was assessed with the enzyme-modified comet assay, and the expression of 40 genes related to cell viability, inflammation, and DNA damage response was evaluated through RT2 gene expression profiling. Despite harmonized protocols used in the two independent laboratories, however, some methodological challenges could affect the results, including sensitivity and reproducibility of the model. Full article
Show Figures

Figure 1

34 pages, 15745 KiB  
Article
A Systematic Genotoxicity Assessment of a Suite of Metal Oxide Nanoparticles Reveals Their DNA Damaging and Clastogenic Potential
by Silvia Aidee Solorio-Rodriguez, Dongmei Wu, Andrey Boyadzhiev, Callum Christ, Andrew Williams and Sabina Halappanavar
Nanomaterials 2024, 14(9), 743; https://doi.org/10.3390/nano14090743 - 24 Apr 2024
Cited by 4 | Viewed by 1635
Abstract
Metal oxide nanoparticles (MONP/s) induce DNA damage, which is influenced by their physicochemical properties. In this study, the high-throughput CometChip and micronucleus (MicroFlow) assays were used to investigate DNA and chromosomal damage in mouse lung epithelial cells induced by nano and bulk sizes [...] Read more.
Metal oxide nanoparticles (MONP/s) induce DNA damage, which is influenced by their physicochemical properties. In this study, the high-throughput CometChip and micronucleus (MicroFlow) assays were used to investigate DNA and chromosomal damage in mouse lung epithelial cells induced by nano and bulk sizes of zinc oxide, copper oxide, manganese oxide, nickel oxide, aluminum oxide, cerium oxide, titanium dioxide, and iron oxide. Ionic forms of MONPs were also included. The study evaluated the impact of solubility, surface coating, and particle size on response. Correlation analysis showed that solubility in the cell culture medium was positively associated with response in both assays, with the nano form showing the same or higher response than larger particles. A subtle reduction in DNA damage response was observed post-exposure to some surface-coated MONPs. The observed difference in genotoxicity highlighted the mechanistic differences in the MONP-induced response, possibly influenced by both particle stability and chemical composition. The results highlight that combinations of properties influence response to MONPs and that solubility alone, while playing an important role, is not enough to explain the observed toxicity. The results have implications on the potential application of read-across strategies in support of human health risk assessment of MONPs. Full article
Show Figures

Figure 1

Other

Jump to: Research

21 pages, 2238 KiB  
Systematic Review
In Vitro Toxicological Insights from the Biomedical Applications of Iron Carbide Nanoparticles in Tumor Theranostics: A Systematic Review and Meta-Analysis
by Maria Antoniou, Georgia Melagraki, Iseult Lynch and Antreas Afantitis
Nanomaterials 2024, 14(9), 734; https://doi.org/10.3390/nano14090734 - 23 Apr 2024
Cited by 1 | Viewed by 1474
Abstract
(1) Background: Despite the encouraging indications regarding the suitability (biocompatibility) of iron carbide nanoparticles (ICNPs) in various biomedical applications, the published evidence of their biosafety is dispersed and relatively sparse. The present review synthesizes the existing nanotoxicological data from in vitro studies relevant [...] Read more.
(1) Background: Despite the encouraging indications regarding the suitability (biocompatibility) of iron carbide nanoparticles (ICNPs) in various biomedical applications, the published evidence of their biosafety is dispersed and relatively sparse. The present review synthesizes the existing nanotoxicological data from in vitro studies relevant to the diagnosis and treatment of cancer. (2) Methods: A systematic review was performed in electronic databases (PubMed, Scopus, and Wiley Online Library) on December 2023, searching for toxicity assessments of ICNPs of different sizes, coatings, and surface modifications investigated in immortalized human and murine cell lines. The risk of bias in the studies was assessed using the ToxRTool for in vitro studies. (3) Results: Among the selected studies (n = 22), cell viability emerged as the most frequently assessed cellular-level toxicity endpoint. The results of the meta-analysis showed that cell models treated with ICNPs had a reduced cell viability (SMD = −2.531; 95% CI: −2.959 to −2.109) compared to untreated samples. A subgroup analysis was performed due to the high magnitude of heterogeneity (I2 = 77.1%), revealing that ICNP concentration and conjugated ligands are the factors that largely influence toxicity (p < 0.001). (4) Conclusions: A dose-dependent cytotoxicity of ICNP exposure was observed, regardless of the health status of the cell, tested organism, and NP size. Inconsistent reporting of ICNP physicochemical properties was noted, which hinders comparability among the studies. A comprehensive exploration of the available in vivo studies is required in future research to assess the safety of ICNPs’ use in bioimaging and cancer treatment. Full article
Show Figures

Figure 1

Back to TopTop